ClinVar Miner

Submissions for variant NM_000260.4(MYO7A):c.1903T>C (p.Cys635Arg)

dbSNP: rs797044514
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000155931 SCV000205643 uncertain significance not specified 2013-08-16 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Pathogenic. The Cys635Arg v ariant in MYO7A has not been reported in individuals with hearing loss and is ab sent from large population studies. Computational analyses (biochemical amino ac id properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Cy s635Arg variant may impact the protein, particularly in light of the alteration of a Cysteine residue which is more likely to affect protein structure. In summa ry, the clinical significance of this variant cannot be determined with certaint y; however based upon the computational data and absence in the general populati on, we would lean towards a more likely pathogenic role.
Invitae RCV001347350 SCV001541606 uncertain significance not provided 2022-06-27 criteria provided, single submitter clinical testing This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 635 of the MYO7A protein (p.Cys635Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Usher syndrome type 1 (PMID: 27743452). ClinVar contains an entry for this variant (Variation ID: 179146). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO7A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001347350 SCV001819255 likely pathogenic not provided 2019-12-10 criteria provided, single submitter clinical testing Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28944237, 27743452)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.